补气活血汤联合经皮椎间孔镜治疗腰椎间盘突出症临床观察

Clinical Observation on treatmentof lumbar disc herniation by Buqihuoxue Decoction combined with percutaneous endoscopic lumbar discectomy

目的观察补气活血汤联合经皮椎间孔镜治疗腰椎间盘突出症的临床疗效。方法选取2015年4月~2017年3月宝鸡市中医医院骨科收治的50例腰椎间盘突出症患者,按随机数字表法分为对照组25例(经皮椎间孔镜治疗)和治疗组25例(补气活血汤联合经皮椎间孔镜治疗)。分别在术前、术后1周、术后1个月及术后6个月对疼痛的视觉模拟评分(VAS评分)、功能障碍指数(ODI指数)进行比较。治疗期间定期监测患者肝肾功能及药物不良反应。结果术后两组患者的VAS评分及ODI较术前均有改善,差异有统计学意义(P<0.05);治疗组术后1周、术后1个月、术后6个月VAS评分及ODI指数均明显优于对照组,差异有统计学意义(P<0.05)。所有患者在治疗期间未出现与药物有关的胃肠道反应及全身不适。结论补气活血汤联合经皮椎间孔镜治疗腰椎间盘突出症安全、有效,中西医结合治疗取得良好效果。

Objeetive To observe clinical effect of Buqihuoxue Decoction and percutaneous endoscopic lumbar discectomy on lumbar disc herniation.Methods From April 2015 to March 2017,in Department of Orthopedics,Baoji Hospital of Chinese Medicine,50 patients with lumbar intervertebral disc herniation were divided into control group 25 cases(given percutaneous intervertebral endoscopy)and treatment group 25 cases(given Buqihuoxue Decoction and percutaneous intervertebral endoscopy).The visual analogue score(VAS score)and Oswestry disability index(ODI index)were compared the preoperation,1 week,1 month,and 6 months after surgery.During treatment,the function of liver and kidney,adverse drug reactions were monitored regularly.Results After treatment,the VAS score and ODI index in two groups were improved than before treatment,the differences were statistically significant(P<0.05);the VAS score and ODI index in the treatment group were significantly lower than the control group on 1 week,1 month,and 6 months,the differences were statistically significant(P<0.05).There was no drug-related gastrointestinal reaction and general discomfort in all patients.Conclusion Buqihuoxue Decoction combined with percutaneous transforaminal endoscope for the treatment of lumbar disc herniation is safe and effective.The combination of Chinese and Western medicine has achieved good results.